TrialThe Journal of infectious diseases2015

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

Patricia L Winokur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.